ALGN vs ZBH: stock comparison and AI forecast
Align Technology Inc (ALGN) and Zimmer Biomet Holdings, Inc. (ZBH) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALGN Align Technology Inc
- Price
- $159.37 -5.4% · 6M
- Market Cap
- $11.32B
- P/E Ratio
- 23.2x
- Size
- large-cap
- AI Forecast
ZBH Zimmer Biomet Holdings, Inc.
- Price
- $97.06 +16.9% · 6M
- Market Cap
- $20.38B
- P/E Ratio
- 21.9x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ZBH is 1.8 times larger than ALGN by market capitalization ($20.38B against $11.32B).
- ZBH trades at 21.9 times trailing earnings, ALGN at 23.2 times.
- Over the last six months ZBH returned +16.9% and ALGN -5.4%.
- ALGN turns 11.8% of its revenue into net income, against 8.9% for ZBH.
- ZBH carries 0.85 times debt per unit of equity, against 0.51 times for ALGN.
- ZBH yields 0.92% in dividends; ALGN pays none.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALGN | ZBH |
|---|---|---|
| Market Cap | $11.32B | $20.38B |
| P/E Ratio | 23.23x | 21.94x |
| P/B Ratio | 2.63x | 1.60x |
| Dividend Yield | – | 0.92% |
| EPS | $6.86 | $4.87 |
| Book Value/Share | $60.61 | $66.67 |
| Revenue/Share | $58.54 | $44.93 |
| FCF/Share | $8.48 | $8.62 |
Profitability & Margins
| Metric | ALGN | ZBH |
|---|---|---|
| ROE | 11.4% | 6.0% |
| ROA | 7.5% | 3.3% |
| ROIC | 13.5% | 5.8% |
| Gross Margin | 69.1% | 69.7% |
| Operating Margin | 14.9% | 13.6% |
| Net Margin | 11.8% | 8.9% |
| EBT Margin | 15.5% | 10.3% |
| Tax Rate | 23.6% | 13.1% |
Financial Health
| Metric | ALGN | ZBH |
|---|---|---|
| Current Ratio | 1.42x | 1.46x |
| Quick Ratio | 1.31x | 0.79x |
| D/E Ratio | 0.51x | 0.85x |
| Financial Leverage | 1.51x | 1.85x |
| Interest Coverage | 518.2x | – |
| Working Capital | $813M | $1.63B |
Cash Flow
| Metric | ALGN | ZBH |
|---|---|---|
| Operating Cash Flow | $750M | $1.88B |
| Free Cash Flow | $602M | $1.64B |
| Capital Spending | -$147M | -$241M |
| OCF Growth YoY | 14.3% | 11.8% |
| FCF Growth YoY | 6.3% | 10.7% |
| FCF/Sales | 14.5% | 19.2% |
| CapEx/Sales | 3.5% | 2.8% |
Operational Efficiency
| Metric | ALGN | ZBH |
|---|---|---|
| Asset Turnover | 0.64x | 0.36x |
| Receivables Turnover | 3.6x | 4.7x |
| Inventory Turnover | 5.7x | 1.1x |
| Fixed Assets Turnover | 3.7x | 3.7x |
| Days Sales Outstanding | 102 days | 77 days |
| Days Inventory | 64 days | 332 days |
| Payables Period | 34 days | 50 days |
| Cash Conversion Cycle | 133 days | 360 days |
Income Statement
| Metric | ALGN | ZBH |
|---|---|---|
| Total Revenue | $4.16B | $8.57B |
| Operating Income | $620M | $1.16B |
| Net Income | $492M | $767M |
| R&D Expense | $378M | $433M |
| SG&A Expense | $1.78B | $3.48B |
| Cost of Goods Sold | $1.28B | $2.60B |
Dividend & Shareholder Information
| Metric | ALGN | ZBH |
|---|---|---|
| Dividends Per Share | – | $0.98 |
| Payout Ratio | – | 20.1% |
| Shares Outstanding | 71M | 191M |
| Net Income Growth | 30.0% | -4.7% |
| EPS Growth | 32.7% | 23.3% |
ALGN vs ZBH: stock comparison and AI forecast
Which is bigger, ALGN or ZBH?
ZBH is 1.8 times larger than ALGN by market capitalization ($20.38B against $11.32B).
Which is cheaper on earnings, ALGN or ZBH?
ZBH trades at 21.9 times trailing earnings, ALGN at 23.2 times.
Which stock performed better over the last six months, ALGN or ZBH?
Over the last six months ZBH returned +16.9% and ALGN -5.4%.
Which one does Intratio's AI model rank higher, ALGN or ZBH?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.